News Releases - Apotex Investor Relations https://investors.apotex.com/ Explore Apotex Investor Relations, including financial performance, stock data, annual reports, and latest corporate news. Apotex Health Corp. files final prospectus and announces pricing of upsized initial public offering https://investors.apotex.com/2026-06-10-Apotex-Health-Corp-files-final-prospectus-and-announces-pricing-of-upsized-initial-public-offering Wed, 10 Jun 2026 11:13:00 -0400 https://investors.apotex.com/2026-06-10-Apotex-Health-Corp-files-final-prospectus-and-announces-pricing-of-upsized-initial-public-offering Apotex Health Corp. upsizes its initial public offering https://investors.apotex.com/2026-06-09-Apotex-Health-Corp-upsizes-its-initial-public-offering Tue, 09 Jun 2026 11:12:00 -0400 https://investors.apotex.com/2026-06-09-Apotex-Health-Corp-upsizes-its-initial-public-offering Apotex launches sitagliptin tablets and sitagliptin and metformin hydrochloride tablets, eligible for 180-day shared exclusivity https://investors.apotex.com/2026-06-03-Apotex-launches-sitagliptin-tablets-and-sitagliptin-and-metformin-hydrochloride-tablets,-eligible-for-180-day-shared-exclusivity Wed, 03 Jun 2026 09:33:00 -0400 https://investors.apotex.com/2026-06-03-Apotex-launches-sitagliptin-tablets-and-sitagliptin-and-metformin-hydrochloride-tablets,-eligible-for-180-day-shared-exclusivity Apotex Health Corp. launches its initial public offering https://investors.apotex.com/2026-06-01-Apotex-Health-Corp-launches-its-initial-public-offering Mon, 01 Jun 2026 09:32:00 -0400 https://investors.apotex.com/2026-06-01-Apotex-Health-Corp-launches-its-initial-public-offering APOTEX HEALTH CORP. FILES PRELIMINARY PROSPECTUS FOR INITIAL PUBLIC OFFERING https://investors.apotex.com/2026-05-28-APOTEX-HEALTH-CORP-FILES-PRELIMINARY-PROSPECTUS-FOR-INITIAL-PUBLIC-OFFERING Thu, 28 May 2026 13:10:00 -0400 https://investors.apotex.com/2026-05-28-APOTEX-HEALTH-CORP-FILES-PRELIMINARY-PROSPECTUS-FOR-INITIAL-PUBLIC-OFFERING